Activation of alveolar macrophages and lung host defenses using transfer of the interferon-γ gene

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 272, Issue 5 16-5, 1997, Pages

  Lei, Dinghua ^a   Lancaster Jr , Jack R ^a   Joshi, Mahesh S ^a   Nelson, Steve ^a   Stoltz, David ^a   Bagby, Gregory J ^a   Odom, Guy ^a   Shellito, Judd E ^a   Kolls, Jay K ^a,b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LSU Section of Pulmonary/Critical Can Medicine   (United States)

Author keywords

Cytokine; Gene therapy; Pneumonia; Tumor necrosis factor

Indexed keywords

GAMMA INTERFERON; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HOST RESISTANCE; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; LUNG ALVEOLUS MACROPHAGE; MALE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RAT;

EID: 0030987797     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1997.272.5.l852     Document Type: Article

References (36)

1. Badaro, R., E. Falcoff, F. Badaro, E. M. Carvalho, D. Pedral-Sampaio, A. Barral, J. S. Carvalho, M. Barral-Netto, M. Brandley, and L. Silva. Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma. N. Engl. J. Med. 322: 16-21, 1990.
2. Bagby, G. J., K. J. Plessala, L. A. Wilson, J. J. Thompson, and S. Nelson. Divergent efficacy of antibody to tumor necrosis factor-alpha in intravascular and peritonitis models of sepsis. J. Infect. Dis. 163: 83-88, 1991.
3. Beck, J. M., H. D. Liggit, E. N. Brunette, H. J. Fuchs, J. E. Shellito, and R. J. Debs. Reduction in intensity of Pneumocystis carinii pneumonia in mice by aerosol administration of interferon-gamma. Infect. Immun. 59: 3859-3862, 1991.
4. Bernhisel, Broadbent, J., E. E. Camargo, H. S. Jaffe, and H. M. Lederman. Recombinant human interferon-gamma as adjunct therapy for Aspergillus infection in a patient with chronic granulomatous disease. J. Infect. Dis. 163: 908-911, 1991.
5. Black, C. M., J. R. Catterall, and J. S. Remington. In vivo and in vitro activation of alveolar macrophages by recombinant inteferon-gamma. J. Immunol. 138: 491-495, 1987.
6. Collart, M. A., D. Belin, J. D. Vassalli, S. de Kossodo, and P. Vassalli. Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors. J. Exp. Med. 164: 2113-2118, 1986.
7. Gallin, J. I., J. M. Farber, S. M. Holland, and T. B. Nutman. Interferon-gamma in the management of Infectious Diseases. Ann. Intern. Med. 123: 216-224, 1995.
8. Graham, F. L., and L. Prevec. Manipulation of adenovirus vectors. In: Methods in Molecular Biology: Gene Transger and Expression Protocols, edited by E. J. Murray. Clifton, NJ: Huaman Press, 1991, p. 109-128.
9. Granger, D. L., R. R. Taintor, K. S. Boockvar, and J. B. Hibbs. Methods: a companion to methods in enzymology. Methods Enzymol. 7: 78-83, 1995.
10. Greenberg, S. S., J. Xie, K. O. Joseph, J. Kolls, and W. Summer. In vivo administration of endotoxin and tumor necrosis factor-alpha produce different effects on constitutive and inducible nitric oxide synthase activity in rat neutrophils and aorta ex vivo. Proc. Soc. Exp. Biol. Med. 208: 199-208, 1995.
11. Greenberger, M. J., R. M. Strieter, S. L. Kunkel, J. M. Danforth, L. L. Laichalk, D. C. McGillicuddy, and T. J. Standiford. Neutralization of macrophage inflammatory protein-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumonia. J. Infect. Dis. 173: 159-165, 1996.
12. Hille, R., J. S. Olson, and G. Palmer. Spectral transitions of nitrosyl hemes during ligand binding to hemoglobin. J. Biol. Chem. 254: 12110-12120, 1979.
13. Jaffe, H. A., R. Buhl, A. Mastangeli, K. J. Holroyd, C. Saltini, D. Czerski, H. S. Jaffe, S. Kramer, S. Sherwin, and R. G. Crystal. Organ specific cytokine therapy. Local activation of mononuclear phagocytes by delivery of an aerosol of recombinant interferon-gamma to the human lung. J. Clin. Invest. 88: 297-302, 1991.
14. Kolls, J. K., D. Lei, S. Greenberg, S. Nelson, and B. Beutler. Adenovirus-mediated blockade of tumor necrosis factor in mice protects against endotoxic shock yet impairs pulmonary host defense. J. Infect. Dis. 171: 570-575, 1995.
15. Kolls, J. K., D. Lei, G. Odom, S. Nelson, W. R. Summer, M. A. Gerber, and J. E. Shellito. Use of transient CD4-lymphocyte depletion to prolong transgene expression of E1-deleted adenoviral vectors. Hum. Gene Ther. 7: 489-497, 1996.
16. Kolls, J., K. Peppel, M. Silva, and B. Beutler. Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer. Proc. Natl. Acad. Sci. USA 91: 215-219, 1994.
17. Kolls, J. K., J. Xie, D. Lei, S. Greenberg, W. R. Summer, and S. Nelson. Differential effects of in vivo ethanol on LPS-induced TNF and nitric oxide production in the lung. Am. J. Physiol. 268 (Lung Cell. Mol. Physiol. 12): L991-L998, 1995.
18. Lai, W. C., M. Bennett, S. P. Pakes, V. Kumar, D. Steutermann, I. Owusu, and A. Mikhael. Reisitance to Mycoplasma pulmonis mediated by activated natural killer cells. J. Infect. Dis. 161: 1269-1275, 1990.
19. Lloyd, A. R., and J. J. Oppenheim. Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response. Immunol. Today 13: 169-172, 1992.
20. Luedke, C., and A. Cerami. Interferon-gamma overcomes glucocorticoid suppression of cachectin/tumor necrosis factor biosynthesis by murine macrophages. J. Clin. Invest. 86: 1234-1240, 1990.
21. Mastrangeli, A., C. Danel, M. A. Rosenfeld, L. D. Stratford-Perricaudet, M. Perricaudet, A. Pavirani, J. Lecocq, and R. G. Crystal. Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer. J. Clin. Invest. 91: 225-234, 1993.
22. Meda, L., S. Gasperini, M. Ceska, and M. A. Cassatella. Modulation of proinflammatory cytokine release from human polymorphonuclear leukocytes by gamma interferon. Cell Immunol. 157: 448-461, 1994.
23. Murray, H. W. Inteferon-gamma, the activated macrophage, and host defense against antimicrobial challenge (Abstract). Ann. Intern. Med. 108: 595-608, 1988.
24. Nagai, H., J. Guo, H. Y. Choi, and V. Kurup. Interferon-gamma and tumor necrosis factor-α protect mice from invasive aspergillosis. J. Infect. Dis. 172: 1554-1560, 1995.
25. Nathan, C. F. Secretory products of macrophages. J. Clin. Invest. 79: 319-326, 1987.
26. Nathan, C. F., H. W. Murray, M. E. Wiebe, and B. Y. Rubin. Identification of inteferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and anitimicrobial activity (Abstract). J. Exp. Med. 158: 670-689, 1983.
27. Nathan, C. F., T. J. Prendergast, M. E. Wiebe, E. R. Stanley, E. Platzer, H. G. Remold, K. Welte, B. Y. Rubin, and H. W. Murray. Activation of human macrophages. Comparison of other cytokines with intefron-gamma. J. Exp. Med. 160: 600-605, 1984.
28. Nelson, S., G. J. Bagby, B. Bainton, L. A. Wilson, J. J. Thompson, and W. R. Summer. Compartmentalization of intaalveolar and systemic lipopolysaccharide-induced tumor necrosis factor and the pulmonary inflammatory response. J. Infect. Dis. 159: 189-194, 1989.
29. Nelson, S., G. J. Bagby, and W. R. Summer. Effect of Alcohol on TNF and Host Defense. In: Alcohol, Immunomodulation, and AIDS. New York: Liss, 1990, p. 211-220.
30. Schnyder-Candrian, S., R. M. Strieter, S. L. Kunkel, and A. Walz. Interferon-alpha and interferon-gamma down-regulate the production of interleukin-8 and ENA-78 in human monocytes. J. Leukoc. Biol. 57: 929-935, 1995.
31. Sibille, Y., and H. Y. Reynolds. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am. Rev. Respir. Dis. 141: 471-501, 1990.
32. Simon, R. H., J. F. Engelhardt, Y. Yang, M. Zepeda, S. Weber-Pendleton, M. Grossman, and J. M. Wilson. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: Toxicity study. Hum. Gene Ther. 4: 771-780, 1993.
33. Skerrett, S. J., and T. R. Martin. Intratracheal interferon-gamma augments pulmonary defenses in experimental legionellosis. Am. J. Respir. Crit. Care Med. 149: 50-58, 1994.
34. Suzuki, Y., K. Joh, and A. Kobayashi. Tumor necrosis factor-independent protective effect of recombinant IFN-gamma against acute toxoplasmosis in T-cell deficient mice. J. Immunol. 147: 2728-2733, 1991.
35. Vecchiarelli, A., T. Todisco, M. Puliti, M. Dottorini, and F. Bistoni. Modulation of anti-candida activity of human alveolar macrophages by inteferon-gamma or interleukin-1-alpha. Am. J. Respir. Cell Mol. Biol. 1: 49-55, 1989.
36. Woodman, R. C., R. W. Erickson, J. Rae, H. S. Jaffe, and J. T. Curnutte. Prolonged recombinant interferon-gamma therapy in chronic granulomatous disease: evidence against enhanced neutrophil oxidase activity. Blood 79: 1558-1562, 1992.